Michael A. Dawes, MD

Clinical Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Michael Dawes, M.D. is Clinical Professor in Psychiatry at Boston University School of Medicine (BUSM). Dr. Dawes is Program Director, BMC-VA Addiction Psychiatry Fellowship. Dr. Dawes has been recipient of a Mentored Clinical Scientist Development Award from the National Institute on Drug Abuse, and has been PI and Site-PI on clinical and prospective studies funded by the National Institutes of Health. He has experience designing and implementing quality improvement and systems redesign projects in the Veterans Healthcare Administration and has served as a site-PI for a multi-site study. He is currently Co-PD on a Health Resources and Services Administration (HRSA) Addiction Medicine Fellowship grant. Dr. Dawes has mentored and supervised faculty as well as many residents, fellows, and other trainees with interests in Addiction Psychiatry, Addiction Medicine, and clinical research in populations with substance use disorders. He is interested in training fellows to do clinical research, including research and implementation science addressing access to treatment for individuals and populations with substance use disorders.

Publications

  • Published 10/30/2024

    Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Hagle H, Joudrey PJ, Molfenter T, Levin FR, Fiellin DA, Edelman EJ. Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National Survey. J Addict Med. 2025 Mar-Apr 01; 19(2):150-156. PMID: 39475119.

    Read at: PubMed

  • Published 1/11/2022

    Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. J Addict Med. 2022 Sep-Oct 01; 16(5):505-513. PMID: 35020698.

    Read at: PubMed

  • Published 1/1/2022

    Hagedorn HJ, Wisdom JP, Gerould H, Pinsker E, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Harris AHS. Alcohol use disorder pharmacotherapy and treatment in primary care (ADaPT-PC) trial: Impact on identified barriers to implementation. Subst Abus. 2022; 43(1):1043-1050. PMID: 35467489.

    Read at: PubMed

  • Published 8/9/2021

    Blevins D, Henry BF, Sung M, Edelman EJ, Black AC, Dawes M, Molfenter T, Hagle H, Drexler K, Cates-Wessel K, Levin FR. Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National Survey. Psychiatr Serv. 2022 Apr 01; 73(4):374-380. PMID: 34369804.

    Read at: PubMed

  • Published 9/22/2020

    Baig MR, Ouyang S, Mata-Galán E, Dawes MA, Roache JD. A Comparison of Cognitive Processing Therapy and Seeking Safety for the Treatment of Posttraumatic Stress Disorder in Veterans. Psychiatr Q. 2021 06; 92(2):735-750. PMID: 32964375.

    Read at: PubMed

Other Positions

  • Program Director, Addiction Psychiatry Fellowship
    Boston University Chobanian & Avedisian School of Medicine

Education

  • University of North Carolina School of Medicine, MD
  • University of North Carolina at Chapel Hill, BA